HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature

Mammary Paget’s disease (MPD) is a rare histological condition, accounting for 1-4% of female breast cancers, which may appear either independently (1.4-13% of the cases), or in association with an in situ or invasive ductal carcinoma (approximately 90% of the cases). The purpose of this article is...

Full description

Saved in:
Bibliographic Details
Main Authors: Luana-Andreea Boșoteanu, Mariana Așchie, Cristian Ionuţ Orǎșanu, Mădălina Boșoteanu
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Case Reports in Pathology
Online Access:http://dx.doi.org/10.1155/2023/1101130
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559583098306560
author Luana-Andreea Boșoteanu
Mariana Așchie
Cristian Ionuţ Orǎșanu
Mădălina Boșoteanu
author_facet Luana-Andreea Boșoteanu
Mariana Așchie
Cristian Ionuţ Orǎșanu
Mădălina Boșoteanu
author_sort Luana-Andreea Boșoteanu
collection DOAJ
description Mammary Paget’s disease (MPD) is a rare histological condition, accounting for 1-4% of female breast cancers, which may appear either independently (1.4-13% of the cases), or in association with an in situ or invasive ductal carcinoma (approximately 90% of the cases). The purpose of this article is to highlight the histopathological challenges related to the microscopical polymorphism of this disease and the utmost importance of immunohistochemistry in the thorough process of Paget’s disease differential diagnosis. Moreover, the primary objective of this review of literature was to corroborate the existing data concerning the potential peculiar immunohistochemical profile that mammary Paget’s disease might express. We report the case of a 44-year-old female patient, histopathologically diagnosed with HER2-negative MPD accompanying an invasive mammary carcinoma. The histopathological and immunohistochemical approach is derived from the exigency of excluding the possibility of synchronous tumors—a mammary invasive carcinoma, accompanied by another component with MPD phenotypic mimicry. The unexpected negative HER2 reaction is conducted to a primary focus on excluding a malignant melanoma in situ. The absence of MelanA and S100 immunoexpression and lack of pigmentation and clinical aspects infirmed it. Bowen’s disease was invalidated by its rare presentation in the breast cutaneous tissue and the absence of individual risk factors suggestive of an existing immunosuppressive status. In the case of similar morphoimmunohistochemical aspects, significant expression of Ki-67 signals MPD, an immunoreactivity that helped distinguish the cellular population from Toker cells. The great similarity of MPD with other benign and malignant cutaneous tumors might determine delay or misdiagnosis. Thus, the utmost importance of immunohistochemistry is reflected in its prognostic significance and geared towards extending the therapeutic arsenal.
format Article
id doaj-art-c89509a0518e4f769a6887d18a3f5c79
institution Kabale University
issn 2090-679X
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Case Reports in Pathology
spelling doaj-art-c89509a0518e4f769a6887d18a3f5c792025-02-03T01:29:48ZengWileyCase Reports in Pathology2090-679X2023-01-01202310.1155/2023/1101130HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the LiteratureLuana-Andreea Boșoteanu0Mariana Așchie1Cristian Ionuţ Orǎșanu2Mădălina Boșoteanu3Department of DermatologyClinical Service of PathologyClinical Service of PathologyClinical Service of PathologyMammary Paget’s disease (MPD) is a rare histological condition, accounting for 1-4% of female breast cancers, which may appear either independently (1.4-13% of the cases), or in association with an in situ or invasive ductal carcinoma (approximately 90% of the cases). The purpose of this article is to highlight the histopathological challenges related to the microscopical polymorphism of this disease and the utmost importance of immunohistochemistry in the thorough process of Paget’s disease differential diagnosis. Moreover, the primary objective of this review of literature was to corroborate the existing data concerning the potential peculiar immunohistochemical profile that mammary Paget’s disease might express. We report the case of a 44-year-old female patient, histopathologically diagnosed with HER2-negative MPD accompanying an invasive mammary carcinoma. The histopathological and immunohistochemical approach is derived from the exigency of excluding the possibility of synchronous tumors—a mammary invasive carcinoma, accompanied by another component with MPD phenotypic mimicry. The unexpected negative HER2 reaction is conducted to a primary focus on excluding a malignant melanoma in situ. The absence of MelanA and S100 immunoexpression and lack of pigmentation and clinical aspects infirmed it. Bowen’s disease was invalidated by its rare presentation in the breast cutaneous tissue and the absence of individual risk factors suggestive of an existing immunosuppressive status. In the case of similar morphoimmunohistochemical aspects, significant expression of Ki-67 signals MPD, an immunoreactivity that helped distinguish the cellular population from Toker cells. The great similarity of MPD with other benign and malignant cutaneous tumors might determine delay or misdiagnosis. Thus, the utmost importance of immunohistochemistry is reflected in its prognostic significance and geared towards extending the therapeutic arsenal.http://dx.doi.org/10.1155/2023/1101130
spellingShingle Luana-Andreea Boșoteanu
Mariana Așchie
Cristian Ionuţ Orǎșanu
Mădălina Boșoteanu
HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
Case Reports in Pathology
title HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
title_full HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
title_fullStr HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
title_full_unstemmed HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
title_short HER2 Negative Mammary Paget’s Disease or In Situ Melanoma? A Case Report and Review of the Literature
title_sort her2 negative mammary paget s disease or in situ melanoma a case report and review of the literature
url http://dx.doi.org/10.1155/2023/1101130
work_keys_str_mv AT luanaandreeabosoteanu her2negativemammarypagetsdiseaseorinsitumelanomaacasereportandreviewoftheliterature
AT marianaaschie her2negativemammarypagetsdiseaseorinsitumelanomaacasereportandreviewoftheliterature
AT cristianionutorasanu her2negativemammarypagetsdiseaseorinsitumelanomaacasereportandreviewoftheliterature
AT madalinabosoteanu her2negativemammarypagetsdiseaseorinsitumelanomaacasereportandreviewoftheliterature